PSMA is a transmembrane glycoprotein, overexpressed in prostate cancer cells, and radiolabeled small molecules with high affinity to its active extracellular centers underlie the mechanism of this imaging technique (7). The gene discussed is FOLH1; the disease is prostate cancer.